Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA (2004) Tenyears‘ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350: 1189–99
Cranney A, Guyatt G, Krolicki N, Wech V, Griffith L, Adachi DJ, Shea B, Tugwell P, Wells G (2001) A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis. Osteoporosis Research Advisory Group. Osteoporos Int 12: 140–51
Delmas PD, Genant HK, Crans GG, Stock JL, Wong M, Siris E, Adachi JD (2003) Secerity of prevalent fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 33: 522–32
Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genent HK, Christiansen C, Delmas PD, Znachetter JR, Stakkestad J, Glueer CC (1999) Reduktion of vertebral frakture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 282: 637–45
Kanis JA et al (2004) A meta-analysis of previours fracture and subsequent frakture risk. Bone 35(2): 357–82
Kains JA et al (2004) Smoking and fracture risk: a meta-analysis Osteoporos Int. Jun 3 [Epub ahead of print]
Klotzbuecher CM, Ross BD, Landsman PB, Abbot TA III, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15: 721–39
Lips P, Graafmans WC, Ooms ME, Bezmer PD, Bouter LM (1996) Vitamin D supplementation and fracture incidence in elderly persons:a randomized, placebo-controlled trial. Ann Intern Med 124: 400–6
Looker AC, Bauer DC, Chesnut III CH, Gundberg CM, Hochberg MC, Klee G, Kleerekoper M, Watts NB, Bell NH (2000) Clinical use of biochemical markers of bone remodelling: current status and future directions. Osteoporos Int 11: 467–80
Mackerras D, Lumley T (1997) First — and second — jear effects in trials of calcium supplementation on the loss of bone density in postmenopausal women. Bone 21: 527–33
Neer RM, Arnaud CD, Znachetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effekt of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344: 1434–41
Recker RR, Hinders S, Davis KM, Heaney RP, Stegman MR (1996) Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res, 1961–6
Roy DK et al (2003) European Prospektive Osteoporosis Study (EPOS) Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS) Osteoporos Int 14(1): 19–26
Tilyard MW, Spears GF, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326: 406–8
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag/Wien
About this chapter
Cite this chapter
Ausserwinkler, M. (2005). Osteoporose. In: Likar, R., Bernatzky, G., Pipam, W., Janig, H., Sadjak, A. (eds) Lebensqualität im Alter. Springer, Vienna. https://doi.org/10.1007/3-211-27182-1_19
Download citation
DOI: https://doi.org/10.1007/3-211-27182-1_19
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-21197-7
Online ISBN: 978-3-211-27182-7
eBook Packages: Medicine (German Language)